Masson’s trichrome staining: the cell nuclei are blue-black, the cytoplasms (cell bodies) are mauve and the collagen fibers are green.
Credit: Riccardo Di Corato – laboratoire MSC (CNRS/Université Paris Diderot)
By combining, in a liposome, magnetic nanoparticles and photosensitizers that are simultaneously and remotely activated by external physical stimuli (a magnetic field and light), scientists obtained total tumor regression in mice.
Non-toxic when they are not activated, such therapies can also achieve a reduction in adverse effects. These results demonstrate the importance of multiple treatments.
One of the strategies employed to limit the adverse effects of cancer therapies is the development of nanocarrier systems that can convey active ingredients to target tumor cells. These are referred to as “physical” therapies when the active substances, molecules or nanoparticles, can be remotely activated by external physical stimuli — in this case by light or a magnetic field. In this context, the study team developed a new type of carrier that combines photosensitivity and magnetism. To achieve this, they first encapsulated magnetic nanoparticles in the inner compartment of a liposome in sufficient quantities to render it ultra-magnetic, before incorporating photosensitizers into its lipid bilayer, while preserving an optimum size for circulation in the blood.
These liposomes, containing magnetic nanoparticles and photosensitizers, were injected directly into the tumor in the mouse model. The scientists thus combined two techniques to achieve complete destruction of cancer cells. The first one, magnetic hyperthermia, consists in exciting the nanoparticles with a magnetic field to raise the temperature of the tumor and destroy it.. The second method, photodynamic therapy, is made possible by the photosensitizers, which, when activated, release reactive oxygen species that are toxic to tumor cells. These two physical therapies act in synergy on the activity of the proteins involved in apoptosis, or programmed cell death. Their combination thus induces total regression of the tumor, while a single therapy is not able to stop its growth.
Read more: Combining magnetism and light to fight cancer
The Latest on: Tumor regression
via Google News
The Latest on: Tumor regression
- Increased Risk of Skin Cancer Seen in Military Veteranson May 19, 2022 at 8:00 am
For military veterans, future research should be accompanied by systematic efforts to improve skin cancer prevention, treatment, and outcomes among military service members and veterans, according to ...
- Pre-Transplant Malignancy is Associated With Risk of De Novo Malignancy Post-Lung Transplantationon May 19, 2022 at 7:05 am
Find out if a pre-transplant malignancy is associated with an increased risk of developing de novo malignancy after a lung transplant. Check out now!
- TransCode Therapeutics Acquires Option for Radiotheranostic Technologyon May 19, 2022 at 6:03 am
TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to defeating cancer using RNA therapeutics, is pleased to announce its execution of an option agreement giving TransCode ...
- Biomea Fusion Announces IND Candidate Selection: BMF-500, a Potential Best-in-Class Oral Covalent Inhibitor of FLT3on May 19, 2022 at 5:00 am
BMF-500, an investigational third-generation covalent inhibitor of FLT3, demonstrated picomolar IC50 values across key FLT3 isoforms, potentially making it the most potent inhibitor of its classHighly ...
- Nationwide study of 100 million hospitalizations finds percutaneous coronary intervention is safe for cardio-oncology patientson May 18, 2022 at 3:43 pm
New data from a study of more than 100 million hospitalizations using machine learning augmentation is being presented at the Society for Cardiovascular Angiography & Interventions (SCAI) 2022 ...
- AI Nanotech Sensor Detects Cancer Signals in Bloodon May 18, 2022 at 1:11 pm
and logistic regression. Bayesian optimization was used, as well as custom Python and MATLAB code. According to the researchers, their solution had 87% sensitivity at 98% specificity, and could be ...
- Joost Blok, MD, on Platinum-Based Chemotherapy and Contralateral Testicular Canceron May 16, 2022 at 8:04 am
Although it has been thought that platinum-based chemotherapy is associated with a lower risk for developing a contralateral tumor in patients with testicular cancer, a new population-based cohort ...
- Study published in international journal shows complete tumour regression in cancer patient through Ayurvedaon May 10, 2022 at 5:37 am
One of the successfully treated cancer cases at Pune's Rasayu Cancer Clinic was recently published in the international peer-reviewed journal Clinical Case Reports.
- Study published in international journal shows complete tumor regression in cancer patient through Ayurveda rasayana treatmenton May 8, 2022 at 11:14 pm
But now in a first, one of the successfully treated cancer cases at Pune's Rasayu Cancer Clinic was recently published in the international peer-reviewed journal Clinical Case Reports. According to ...
via Bing News
